{"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:2e10fa61-2ba4-4f5f-9fe7-8b41b0f7329c", "type": "text", "profile": "update", "version": "1", "versioncreated": "2026-09-22T20:04:56.887981Z", "firstcreated": "2026-09-22T20:02:27.573334Z", "pubstatus": "usable", "urgency": 5, "language": "en", "headline": "GLP-1 Weight-Loss Drugs Face Lawsuits Over Rare 'Eye Stroke' Vision Loss", "byline": "Hailey Griffin", "located": "United States", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / Cronkite", "usageterms": "Subscribers may republish this item in full, including translation and trimming, with the credit “Wireva / Cronkite”. Set rel=canonical to https://cronkite.online/news/glp-1-weight-loss-drugs-face-lawsuits-over-rare-eye-stroke-vision-loss/ when publishing on the web.", "description_text": "Hundreds of patients are suing Novo Nordisk and Eli Lilly, alleging that popular GLP-1 medications caused a rare optic nerve condition called NAION. Both companies deny the claims, and regulators have not concluded the drugs cause the condition.", "altids": {"mosaic": "2e10fa61-2ba4-4f5f-9fe7-8b41b0f7329c", "story": "e79e2308-b082-4d35-adaf-a6e9fc751a77", "slug": "glp-1-weight-loss-drugs-face-lawsuits-over-rare-eye-stroke-vision-loss"}, "subject": [{"name": "General news", "rel": "direct", "literal": "general", "code": "medtop:11000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/11000000"}], "place": [{"name": "United States", "literal": "us", "code": "US", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Updated story", "literal": "update"}], "service": [{"name": "Wireva", "literal": "wireva"}], "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:dcb38527-8f3a-4b8f-aa63-2cbf70453275", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "Popular weight-loss drugs face numerous lawsuits over rare ‘eye stroke’ linked to vision loss", "description_text": "GLP-1 Weight-Loss Drugs Face Lawsuits Over Rare 'Eye Stroke' Vision Loss", "copyrightholder": "a57.foxnews.com", "copyrightnotice": "Popular weight-loss drugs face numerous lawsuits over rare ‘eye stroke’ linked to vision loss", "usageterms": "Picture belongs to the source publication: address and terms are delivered, the file is not.", "altids": {"wireva": "dcb38527-8f3a-4b8f-aa63-2cbf70453275"}, "extra": {"wireva:delivery_mode": "link_only", "wireva:rights": {"licence": "", "licence_url": "", "licence_raw": "RSS source", "licence_verified_at": "2026-09-22T20:04:56.905489Z", "attribution_required": true, "attribution_text": "Popular weight-loss drugs face numerous lawsuits over rare ‘eye stroke’ linked to vision loss", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": false, "share_alike_required": false}, "wireva:provenance": {"creator": "", "source_name": "a57.foxnews.com", "source_url": "https://a57.foxnews.com/static.foxnews.com/foxnews.com/content/uploads/2026/09/931/523/close-up-eye.jpg?ve=1&tl=1", "source_page_url": "https://a57.foxnews.com/static.foxnews.com/foxnews.com/content/uploads/2026/09/931/523/close-up-eye.jpg?ve=1&tl=1", "our_page_url": "https://cronkite.online/news/glp-1-weight-loss-drugs-face-lawsuits-over-rare-eye-stroke-vision-loss/"}, "wireva:role": "lead"}, "renditions": {"source": {"href": "https://a57.foxnews.com/static.foxnews.com/foxnews.com/content/uploads/2026/09/931/523/close-up-eye.jpg?ve=1&tl=1", "mimetype": "image/jpeg"}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:e79e2308-b082-4d35-adaf-a6e9fc751a77", "slug": "trump-tells-un-iran-faces-choice-between-deal-and-destruction-20260922", "status": "updated", "languages": ["en", "fr", "it"], "item_count": 11, "is_breaking": false}, "wireva:rights": {"class": "agency_original", "redistribution_allowed": true, "commercial_use_allowed": true, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / Cronkite", "canonical_required": true, "canonical_url": "https://cronkite.online/news/glp-1-weight-loss-drugs-face-lawsuits-over-rare-eye-stroke-vision-loss/", "linkback_required": true, "licence": "Wireva subscriber licence", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 0, "decided_by_rule": "agency_original_verified", "needs_review": false}, "wireva:provenance": {"production_method": "automated", "ai_stages": {"editing": true, "drafting": true, "headline": true, "discovery": true, "classification": true, "image_selection": true, "source_collection": true, "cross_source_comparison": true}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "multi_source", "independent_confirmations": 2, "official_source_used": false, "used_press_release": false, "public_interest": true, "ai_disclosure_required": true, "ai_disclosure_text": "This item was produced with AI assistance under the editorial responsibility of Haydamax OÜ.", "independence_check": {"status": "passed", "score": 0.23, "checked_at": "2026-09-22T20:04:56.902792Z"}}, "wireva:publication": {"name": "Cronkite", "domain": "cronkite.online", "country": "US", "url": "https://cronkite.online/news/glp-1-weight-loss-drugs-face-lawsuits-over-rare-eye-stroke-vision-loss/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/2e10fa61-2ba4-4f5f-9fe7-8b41b0f7329c", "html": "https://wireva.mib.news/item/2e10fa61-2ba4-4f5f-9fe7-8b41b0f7329c/glp-1-weight-loss-drugs-face-lawsuits-over-rare-eye-stroke-vision-loss/", "story": "https://wireva.mib.news/story/trump-tells-un-iran-faces-choice-between-deal-and-destruction-20260922/"}, "wireva:metrics": {"word_count": 716, "char_count": 4507, "reading_time_seconds": 322}}}